Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.23.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Summary of Stock Options Activity

The activity for stock options under the Company’s stock plans for the six months ended June 30, 2023 is as follows:

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

weighted-

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

average

 

 

Per share

 

 

 

 

 

 

 

 

 

average

 

 

contractual

 

 

average

 

 

 

 

 

 

Price per

 

 

exercise

 

 

terms

 

 

intrinsic

 

 

 

Options

 

 

share

 

 

price

 

 

(in years)

 

 

value

 

Outstanding as of December 31, 2022

 

 

348,284

 

 

$1.17-$83.30

 

 

$

44.21

 

 

 

0.43

 

 

$

2.07

 

Exercised

 

 

(54,432

)

 

1.17-8.37

 

 

 

7.03

 

 

 

 

 

 

 

Forfeited

 

 

(4,125

)

 

 

44.19

 

 

 

44.19

 

 

 

 

 

 

 

Expired

 

 

(232,363

)

 

 

44.19

 

 

 

44.19

 

 

 

 

 

 

 

Outstanding as of June 30, 2023

 

 

57,364

 

 

8.37-83.30

 

 

 

79.56

 

 

 

0.57

 

 

 

0.16

 

Vested and exercisable as of June 30, 2023

 

 

57,364

 

 

8.37-83.30

 

 

 

79.56

 

 

 

0.57

 

 

 

0.16

 

Vested and expected to vest as of June 30, 2023

 

 

57,364

 

 

$8.37-$83.30

 

 

$

79.56

 

 

 

0.57

 

 

$

0.16

 

Summary of Restricted Stock Activity

Stock Awards activity for the six months ended June 30, 2023 is summarized below:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

 

 

grant

 

 

 

 

 

 

Performance

 

 

 

 

 

date fair

 

 

 

 

 

 

and

 

 

 

 

 

value

 

Restricted stock units

 

Time-based

 

 

time-based

 

 

Total

 

 

per share

 

Unvested restricted stock units as of December 31, 2022

 

 

820,941

 

 

 

183,197

 

 

 

1,004,138

 

 

$

32.72

 

Granted

 

 

855,708

 

 

 

536,990

 

 

 

1,392,698

 

 

 

15.11

 

Vested

 

 

(167,044

)

 

 

(15,618

)

 

 

(182,662

)

 

 

35.32

 

Forfeited/canceled

 

 

(214,852

)

 

 

(73,185

)

 

 

(288,037

)

 

 

25.97

 

Unvested restricted stock units as of June 30, 2023 (1)

 

 

1,294,753

 

 

 

631,384

 

 

 

1,926,137

 

 

$

21.20

 

Unvested and expected to vest restricted stock units outstanding as of June 30, 2023

 

 

 

 

 

 

 

 

1,369,435

 

 

$

21.64

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

 

 

grant

 

 

 

 

 

 

Performance

 

 

 

 

 

date fair

 

 

 

 

 

 

and

 

 

 

 

 

value

 

Restricted stock awards

 

Time-based

 

 

time-based

 

 

Total

 

 

per share

 

Unvested restricted stock awards outstanding as of December 31, 2022

 

 

786

 

 

 

 

 

 

786

 

 

$

59.55

 

Vested

 

 

(786

)

 

 

 

 

 

(786

)

 

 

59.55

 

Unvested restricted stock awards outstanding as of June 30, 2023 (1)

 

 

 

 

 

 

 

 

 

 

$

 

Unvested and expected to vest restricted stock awards outstanding as of June 30, 2023

 

 

 

 

 

 

 

 

 

 

$

 

 

(1) Outstanding restricted stock units and restricted stock awards are based on the maximum payout of the targeted number of shares.

Summary of Stock-based Compensation Expense

Stock-based compensation expense recognized for the three and six months ended June 30, 2023 and 2022, was as follows:

 

 

 

Three months ended

 

 

Six months ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock units and restricted stock awards

 

$

3,177

 

 

$

2,891

 

 

$

6,482

 

 

$

5,359

 

Employee stock purchase plan

 

 

86

 

 

 

129

 

 

 

223

 

 

 

326

 

Total stock-based compensation expense

 

$

3,263

 

 

$

3,020

 

 

$

6,705

 

 

$

5,685

 

For the three and six months ended June 30, 2023 and 2022, respectively, stock-based compensation expense recognized under ASC 718, included in cost of revenue, research and development expense, sales and marketing expense, and general and administrative expense was as follows:

 

 

 

Three months ended

 

 

Six months ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Cost of revenue

 

$

153

 

 

$

303

 

 

$

237

 

 

$

536

 

Research and development

 

 

376

 

 

 

412

 

 

 

834

 

 

 

796

 

Sales and marketing

 

 

658

 

 

 

766

 

 

 

1,432

 

 

 

1,357

 

General and administrative

 

 

2,076

 

 

 

1,539

 

 

 

4,202

 

 

 

2,996

 

Total stock-based compensation expense

 

$

3,263

 

 

$

3,020

 

 

$

6,705

 

 

$

5,685